EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

PAC ‐ FOS: A novel translational concordance framework identifies preclinical seizure models with highest predictive validity for clinical focal onset seizures

Lyndsey L Anderson iD, Kristopher M Kahlig iD, Melissa L Barker-Haliski iD, Lillian G Matthews iD, Hamish D Toop iD, Brian Hannigan iD, Jacqueline French iD, H Steve White iD, Marcio Souza iD, Steven Petrou iD

Epilepsia · 2025-12 · 66 (12) · 4983-4995

DOI: 10.1111/epi.18592 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, online erschienen am 06.08.2025. Verfasst von Lyndsey L Anderson und 9 weiteren Autor:innen. Beteiligte Einrichtung: Praxis Precision Medicines, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Disease Models, Animal, Seizures, Anticonvulsants, Translational Research, Biomedical. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Central to the development of novel antiseizure medications (ASMs) is testing of antiseizure activity in preclinical models. Although various well‐established models exist, their predictive validity across the spectrum of clinical epilepsies has been less clear. We sought to establish the translational concordance of commonly used preclinical models to define models with the highest predictive clinical validity for focal onset seizures (FOS).

Methods

The Praxis Analysis of Concordance (PAC) framework was implemented to assess the translational concordance between preclinical and clinical ASM response for 32 US Food and Drug Administration‐approved ASMs. Preclinical ASM responses in historically used seizure models were collected. Protective indices based on reported median tolerability and median efficacy values were calculated for each ASM in each preclinical model. A weighted scale representing relative antiseizure effect was used to grade preclinical ASM response for each seizure model. Data depth was further scored based on the number of evaluated ASMs with publicly available data. Established reports of clinical ASM use in patients with FOS were similarly evaluated, and a weighted scale representing prescribing patterns and perceived efficacy was used to grade clinical ASM response. To assess the predictive validity of preclinical models, a unified translational scoring matrix was developed to assign a concordance score spanning the spectrum from complete discordance (−1) to complete concordance (1) between preclinical and clinical ASM responses. Scores were summed and normalized to generate a global translational concordance score.

Results

The preclinical models with the highest translational concordance and greatest data depth for FOS were rodent maximal electroshock seizure (MES), mouse audiogenic seizure, mouse 6 Hz (32 mA), and rat amygdala kindling. Significance The PAC‐FOS framework highlights mouse MES, mouse audiogenic, and mouse 6 Hz (32 mA) as three acute seizure models consistently demonstrating high predictive validity for FOS. We provide a pragmatic decision tree approach to support efficient resource utilization for novel ASM discovery for FOS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease Models, AnimalSeizuresAnticonvulsantsTranslational Research, BiomedicalEpilepsies, PartialAnimalsHumansDrug Evaluation, PreclinicalRatsMiceReproducibility of Results

Stichwörter der Autor:innen

epilepsyfocal seizurespreclinical modelspredictive validitytranslational concordance

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • Praxis Precision Medicines, Boston, Massachusetts, USA.
  • Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington, USA.
  • Department of Pharmacy, Center for Epilepsy Drug Discovery, School of Pharmacy, University of Washington, Seattle, Washington, USA.
  • Department of Neurology and Comprehensive Epilepsy Center, New York University Grossman School of Medicine, New York, New York, USA.

ORCID-Profile: Lyndsey L Anderson, Kristopher M Kahlig, Melissa L Barker-Haliski, Lillian G Matthews, Hamish D Toop, Brian Hannigan, Jacqueline French, H Steve White, Marcio Souza, Steven Petrou

Zitieren

APA

Anderson, L. L., Kahlig, K. M., Barker-Haliski, M. L., Matthews, L. G., Toop, H. D., Hannigan, B., French, J., White, H. S., Souza, M., & Petrou, S. (2025). PAC ‐ FOS: A novel translational concordance framework identifies preclinical seizure models with highest predictive validity for clinical focal onset seizures. Epilepsia, 66(12), 4983-4995. https://doi.org/10.1111/epi.18592

Vancouver

Anderson LL, Kahlig KM, Barker-Haliski ML, Matthews LG, Toop HD, Hannigan B, et al. PAC ‐ FOS: A novel translational concordance framework identifies preclinical seizure models with highest predictive validity for clinical focal onset seizures. Epilepsia. 2025;66(12):4983-4995. doi:10.1111/epi.18592

BibTeX
@article{Anderson2025,
  author = {Anderson, Lyndsey L and Kahlig, Kristopher M and Barker-Haliski, Melissa L and Matthews, Lillian G and Toop, Hamish D and Hannigan, Brian and French, Jacqueline and White, H Steve and Souza, Marcio and Petrou, Steven},
  title = {PAC ‐ FOS: A novel translational concordance framework identifies preclinical seizure models with highest predictive validity for clinical focal onset seizures},
  journal = {Epilepsia},
  year = {2025},
  volume = {66},
  number = {12},
  pages = {4983--4995},
  doi = {10.1111/epi.18592}
}
Kostenlos starten →